Regulation of B Lymphocyte Survival and Differentiation by HSH2
Regulation of B Lymphocyte Survival and Differentiation by HSH2
批准号:
8030421
负责人:
LOUIS B JUSTEMENT
金额:
$31.37万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-03-05 至 2013-02-28
关键词:
Adaptor Signaling ProteinAntigen ReceptorsApoptosisApoptoticAttenuatedAutoimmunityB-Cell DevelopmentB-LymphocytesBindingBiochemicalBone MarrowCD28 geneCD3 AntigensCD4 Positive T LymphocytesCell Differentiation processCell LineCell SurvivalCell physiologyCellsCellular biologyCessation of lifeDNADevelopmentDisease ProgressionDoctor of PhilosophyEffector CellEquilibriumEtiologyEventExhibitsFamilyFlow CytometryGene TargetingGoalsHematopoieticHomeostasisHourImmunofluorescence ImmunologicInterleukin-4IonomycinLaboratoriesLeadLifeLigationLinkLymphocyteLymphocyte BiologyMalignant NeoplasmsMediatingMembraneMitochondriaMolecularMusNatureOuter Mitochondrial MembranePathway interactionsPeripheralPeritoneumPhysiologicalPlayPopulationProteinsRegulationRegulatory PathwayResearch PersonnelRoleSignal TransductionSpleenSrc homology 2 domain-containing, transforming protein 1Staining methodStainsStimulusStructureT-LymphocyteTNFRSF5 geneTNFSF5 geneThymus GlandTissue StainsTransgenesUp-RegulationWestern Blottinganti-IgMcomputerized data processingimmune functioninsightknock-downloss of functionmacrophagenovelpopulation basedprogramsprotein expressionprotein functionreceptorresearch studyresponseretroviral-mediatedsmall hairpin RNAthymocyte
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The goal of this application is to elucidate the physiological role of the novel adaptor protein HSH2 (Hematopoietic SH2 protein) in regulation of B lymphocyte biology. Studies conducted in our laboratory have demonstrated that HSH2 is expressed at low basal levels in splenic B cells and that its expression is induced in response to stimuli that bind to distinct families of receptors that promote survival and differentiation, including CD40L, IL-4, LPS, CpG DMA and BLyS (BAFF). Up-regulation of HSH2 expression was shown to be dependent on activation of NF-?B and correlates with initiation of a survival response that includes up-.regulation of Bcl-XL. Retroviral-mediated expression of HSH2 in the WEHI-231 B cell line, which undergoes apoptosis in response to BCR ligation, was observed to enhance survival and mitochondrial stability. Similarly, enhanced survival of WEHI-231 cells in response to CD40-mediated signaling directly correlated with up-regulation of HSH2 expression. Although HSH2 does not significantly alter BCR-proximal signal transduction, it was observed to maintain mitochondrial stability and this correlated with its ability to block up-regulation of Bim in response to BCR signaling. Moreover, HSH2 was found to interact with the anti-apoptotic protein HAX-1, which possesses a membrane-spanning region that targets it to the outer mitochondrial membrane. Preliminary studies have shown that the interaction between HSH2 and HAX-1 is important for the anti-apoptotic activity of HSH2. Therefore, HSH2 and HAX-1 may function together to regulate mitochondrial integrity and cell survival. To further elucidate the physiological role of HSH2 in regulation of B lymphocyte survival/differentiation, three specific aims have been proposed that will: 1) determine the physiological role of HSH2 in B lymphocyte development, homeostasis and immune function; 2) elucidate the role that HSH2 plays in regulating Bim expression in response to co-stimulation; and 3) determine the functional importance of the interaction between HSH2 and HAX-1 in regulating mitochondrial stability. Because HSH2 expression is induced in response to many of the key stimuli that are known to promote B cell survival and differentiation, this adaptor protein is likely to play an important role in regulating B cell homeostasis and immune function. Therefore, these studies will provide novel insight into the molecular mechanisms that maintain the balance between B lymphocyte survival and death leading to differentiation into humoral effector cells and will provide insight into the etiology and progression of diseases associated with aberrant B cell function, including cancer and autoimmunity.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Differential expression of the adaptor protein HSH2 controls the quantitative and qualitative nature of the humoral response.
接头蛋白 HSH2 的差异表达控制着体液反应的定量和定性。
DOI:
10.4049/jimmunol.1101534
发表时间:
2011
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[King,RGlenn, Herrin,BrantleyR, Justement,LouisB]
通讯作者:
Justement,LouisB
Identification and Analysis of the Physiological Ligand for TLT2
-
批准号:8568235
-
项目类别:
-
资助金额:$20.7万
-
财政年份:2013
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
CD19 Tyrosine-mediated Signal Transduction in vivo
-
批准号:8081969
-
项目类别:
-
资助金额:$9.99万
-
财政年份:2010
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
Regulation of B Lymphocyte Survival and Differentiation by HSH2
-
批准号:7612425
-
项目类别:
-
资助金额:$6.71万
-
财政年份:2008
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
Regulation of B Lymphocyte Survival and Differentiation by HSH2
-
批准号:7191849
-
项目类别:
-
资助金额:$32.63万
-
财政年份:2007
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
Regulation of B Lymphocyte Survival and Differentiation by HSH2
-
批准号:7367189
-
项目类别:
-
资助金额:$32.01万
-
财政年份:2007
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
Regulation of B Lymphocyte Survival and Differentiation by HSH2
-
批准号:7586201
-
项目类别:
-
资助金额:$32.01万
-
财政年份:2007
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
Regulation of B Lymphocyte Survival and Differentiation by HSH2
-
批准号:7775050
-
项目类别:
-
资助金额:$31.69万
-
财政年份:2007
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
CD19 Tyrosine-mediated Signal Transduction in vivo
-
批准号:7647892
-
项目类别:
-
资助金额:$36.25万
-
财政年份:1998
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
CD19 Tyrosine-mediated Signal Transduction in vivo
-
批准号:7533208
-
项目类别:
-
资助金额:$36.25万
-
财政年份:1998
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
CD19 Tyrosine-mediated Signal Transduction in vivo
-
批准号:8289609
-
项目类别:
-
资助金额:$35.53万
-
财政年份:1998
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
CD19 Tyrosine-mediated Signal Transduction in vivo
-
批准号:8079028
-
项目类别:
-
资助金额:$35.53万
-
财政年份:1998
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
CD19 Tyrosine-mediated Signal Transduction in vivo
-
批准号:7880585
-
项目类别:
-
资助金额:$35.89万
-
财政年份:1998
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
MOLECULAR MECHANISMS MEDIATING CD22 ACCESSORY FUNCTION
-
批准号:6631860
-
项目类别:
-
资助金额:$23.46万
-
财政年份:1995
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
MOLECULAR MECHANISMS MEDIATING CD22 ACCESSORY FUNCTION
-
批准号:2376381
-
项目类别:
-
资助金额:$15.58万
-
财政年份:1995
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
MOLECULAR MECHANISMS MEDIATING CD22 ACCESSORY FUNCTION
-
批准号:2849455
-
项目类别:
-
资助金额:$19.37万
-
财政年份:1995
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
MOLECULAR MECHANISMS MEDIATING CD22 ACCESSORY FUNCTION
-
批准号:6373408
-
项目类别:
-
资助金额:$21.73万
-
财政年份:1995
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
MOLECULAR MECHANISMS MEDIATING CD22 ACCESSORY FUNCTION
-
批准号:6169791
-
项目类别:
-
资助金额:$20.21万
-
财政年份:1995
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
MOLECULAR MECHANISMS MEDIATING CD22 ACCESSORY FUNCTION
-
批准号:6510549
-
项目类别:
-
资助金额:$22.77万
-
财政年份:1995
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
MOLECULAR MECHANISMS MEDIATING CD22 ACCESSORY FUNCTION
-
批准号:2667746
-
项目类别:
-
资助金额:$16.2万
-
财政年份:1995
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
MOLECULAR MECHANISMS MEDIATING CD22 ACCESSORY FUNCTION
-
批准号:2072678
-
项目类别:
-
资助金额:$15.31万
-
财政年份:1995
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
海外基金